1. Home
  2. SNCR vs VXRT Comparison

SNCR vs VXRT Comparison

Compare SNCR & VXRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNCR
  • VXRT
  • Stock Information
  • Founded
  • SNCR 2000
  • VXRT N/A
  • Country
  • SNCR United States
  • VXRT United States
  • Employees
  • SNCR N/A
  • VXRT N/A
  • Industry
  • SNCR EDP Services
  • VXRT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SNCR Technology
  • VXRT Health Care
  • Exchange
  • SNCR Nasdaq
  • VXRT Nasdaq
  • Market Cap
  • SNCR 101.2M
  • VXRT 119.0M
  • IPO Year
  • SNCR 2006
  • VXRT N/A
  • Fundamental
  • Price
  • SNCR $11.44
  • VXRT $0.35
  • Analyst Decision
  • SNCR Strong Buy
  • VXRT Strong Buy
  • Analyst Count
  • SNCR 1
  • VXRT 2
  • Target Price
  • SNCR $13.00
  • VXRT $3.00
  • AVG Volume (30 Days)
  • SNCR 141.8K
  • VXRT 1.8M
  • Earning Date
  • SNCR 05-06-2025
  • VXRT 03-20-2025
  • Dividend Yield
  • SNCR N/A
  • VXRT N/A
  • EPS Growth
  • SNCR N/A
  • VXRT N/A
  • EPS
  • SNCR 0.43
  • VXRT N/A
  • Revenue
  • SNCR $173,594,000.00
  • VXRT $28,700,000.00
  • Revenue This Year
  • SNCR $5.08
  • VXRT N/A
  • Revenue Next Year
  • SNCR $2.43
  • VXRT $48.02
  • P/E Ratio
  • SNCR $25.88
  • VXRT N/A
  • Revenue Growth
  • SNCR 5.72
  • VXRT 288.94
  • 52 Week Low
  • SNCR $6.02
  • VXRT $0.34
  • 52 Week High
  • SNCR $15.46
  • VXRT $1.30
  • Technical
  • Relative Strength Index (RSI)
  • SNCR 55.97
  • VXRT 25.21
  • Support Level
  • SNCR $10.55
  • VXRT $0.49
  • Resistance Level
  • SNCR $12.19
  • VXRT $0.60
  • Average True Range (ATR)
  • SNCR 0.78
  • VXRT 0.04
  • MACD
  • SNCR -0.06
  • VXRT -0.01
  • Stochastic Oscillator
  • SNCR 45.56
  • VXRT 4.69

About SNCR Synchronoss Technologies Inc.

Synchronoss Technologies Inc is a leading provider of white-label cloud, messaging, digital and network management solutions that enable its customers to keep subscribers, systems, networks and content in sync. The Synchronoss Personal CloudTM solution is designed to create an engaging and trusted customer experience through ongoing content management and engagement. The Synchronoss Personal CloudTM platform is a secure and highly scalable, white-label platform that allows its customers' subscribers to backup and protect, engage with, and manage their personal content. The company derives revenue from subscriptions and transaction-based fees. A majority of the firm's revenue is generated in the United States, and the rest is from countries across the world.

About VXRT Vaxart Inc

Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.

Share on Social Networks: